Beyond Air (NASDAQ:XAIR) and Sintx Technologies (NASDAQ:SINT) Head to Head Contrast

Sintx Technologies (NASDAQ:SINT) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

Risk & Volatility

Sintx Technologies has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Sintx Technologies and Beyond Air, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	0	0	1	0	3.00
Beyond Air	0	1	2	1	3.00

Sintx Technologies currently has a consensus price target of $28.00, suggesting a potential upside of 748.48%. Beyond Air has a consensus price target of $1.50, suggesting a potential upside of 641.47%. Given Sintx Technologies’ higher probable upside, research analysts plainly believe Sintx Technologies is more favorable than Beyond Air.

Earnings & Valuation

This table compares Sintx Technologies and Beyond Air”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$2.89 million	2.87	-$11.02 million	($50.56)	-0.07
Beyond Air	$1.16 million	15.06	-$60.24 million	($1.06)	-0.19

Sintx Technologies has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Sintx Technologies and Beyond Air’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-483.85%	-203.66%	-104.76%
Beyond Air	-1,258.46%	-213.97%	-104.66%

Insider and Institutional Ownership

18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 0.0% of Sintx Technologies shares are owned by insiders. Comparatively, 19.4% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

About Sintx Technologies

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

About Beyond Air

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.